Tema Etfs LLC Invests $604,000 in CME Group Inc. (NASDAQ:CME)

Tema Etfs LLC purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,600 shares of the financial services provider's stock, valued at approximately $604,000.

A number of other institutional investors have also recently made changes to their positions in the business. SJS Investment Consulting Inc. raised its position in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after acquiring an additional 97 shares in the last quarter. New Age Alpha Advisors LLC boosted its holdings in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares in the last quarter. Financial Life Planners purchased a new position in shares of CME Group in the 4th quarter worth approximately $32,000. Knuff & Co LLC bought a new position in shares of CME Group during the 4th quarter worth approximately $33,000. Finally, Banque Transatlantique SA purchased a new stake in CME Group during the fourth quarter valued at approximately $35,000. Institutional investors own 87.75% of the company's stock.

Insiders Place Their Bets

In other CME Group news, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares of the company's stock, valued at $2,063,885.88. The trade was a 15.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This trade represents a 12.84% decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,884 shares of company stock valued at $7,389,843 in the last three months. 0.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on CME shares. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a report on Monday, March 10th. Bank of America upped their target price on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Barclays upped their price objective on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Finally, Morgan Stanley boosted their target price on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $256.80.

CME Group Price Performance

Shares of CME stock traded up $2.27 on Friday, reaching $284.27. 577,097 shares of the company were exchanged, compared to its average volume of 2,178,514. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $286.48. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The business has a 50-day moving average price of $267.48 and a 200 day moving average price of $248.56. The company has a market cap of $102.44 billion, a price-to-earnings ratio of 29.40, a P/E/G ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the previous year, the firm posted $2.50 EPS. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. Equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.76%. The ex-dividend date is Monday, June 9th. CME Group's payout ratio is currently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.